Viewing Study NCT07012304


Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2025-12-28 @ 1:17 PM
Study NCT ID: NCT07012304
Status: RECRUITING
Last Update Posted: 2025-06-10
First Post: 2025-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy
Sponsor: Yujun DONG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module